Loading data
IMCRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 400.02 m USD | 310.2 m USD | 249.43 m USD | 174.36 m USD | 4.08 m USD |
| Cost of revenue | 5.09 m USD | 2.73 m USD | 1.04 m USD | 1.09 m USD | 0 USD |
| Research and development expense | 274.87 m USD | 222.15 m USD | 163.55 m USD | 101.92 m USD | 100.25 m USD |
| Selling, general and administrative expense | 165.41 m USD | 155.78 m USD | 144.5 m USD | 123.06 m USD | 110.82 m USD |
| Operating profit | -45.35 m USD | -70.46 m USD | -59.65 m USD | -51.71 m USD | -174.59 m USD |
| Interest expense | — | — | 5.15 m USD | 5.41 m USD | 5.57 m USD |
| Profit before tax | -19.1 m USD | -52.94 m USD | -60.89 m USD | -40.88 m USD | -179.88 m USD |
| Income tax expense | 16.41 m USD | -1.85 m USD | -5.6 m USD | 11.66 m USD | 150 k USD |
| Net income (reported basis) | -35.51 m USD | -51.09 m USD | -55.29 m USD | -52.54 m USD | -180.03 m USD |
| Basic earnings per share | -0.71 USD/share | -1.02 USD/share | -1.13 USD/share | -1.15 USD/share | -4.24 USD/share |
| Diluted earnings per share | -0.71 USD/share | -1.02 USD/share | -1.13 USD/share | -1.15 USD/share | -4.24 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.